Metastatic deposits occur to the thyroid gland due to vascular or lymphatic spread. It has been postulated that the rich vasculature of the thyroid makes it particularly liable [
6], but also that the fast flow of blood through the gland may reduce the likelihood of metastatic deposits [
3]. Metastases to the thyroid from nonthyroid malignancies (TM) remain a rare occurrence in clinical practice, comprising only 1.4–3% of all thyroid neoplasms [
4].
Studies from the US and UK [
5,
7] place kidney, followed by colorectal, lung, and breast as the most common primary sources for thyroid metastases, while an Asian series indicate malignancies of the gastrointestinal tract, especially of the upper GI tract, are also responsible [
7]. Other reported primary tumours include neuroendocrine tumours, sarcoma, and more rarely melanoma [
2,
3].
The timing of diagnosis of metastases to the thyroid is variable from time of initial diagnosis to years after treatment. The majority of patients are euthyroid at presentation, with thyrotoxicosis rarely seen [
7]. When it does occur it is thought to be due to hormones leaking from the gland following neoplastic damage [
3]. Metastases to the thyroid can present as a single nodule or as multiple foci within the gland [
4]. 72% of patients with metastases to the thyroid in one study presented with a clinically detectable thyroid nodule [
7], with other studies reporting signs of extrinsic compression at presentation [
2,
3,
5]. In contrast to the much greater preponderance of primary thyroid tumours in women than men, the picture regarding metastases of nonthyroid malignancies to the thyroid gland is less clear. Some studies have reported a slightly higher incidence in women than men [
5], but other series report no sex bias [
7]. A recent review of the last 10 years suggests a female to male ratio of 1.4

:

1 [
3].
Investigation of TM usually proceeds as with the assessment of any thyroid nodule-history, clinical examination, followed by USS and FNAB, with CT and PET imaging also playing a role [
8]. Metastases to the thyroid typically appear ultrasonographically as hypoechoic masses with poorly defined margins and increased vascularisation. Calcification is rarely seen, in contrast to many primary thyroid tumours [
7]. Immunohistochemistry is key in the diagnosis of metastases to the thyroid and the identification of the primary site. A nonthyroidal primary site may be indicated by a failure to react to thyroglobulin, TTF-1, and calcitonin [
7], and indeed metastatic thyroid tumours are almost universal in their failure to react to thyroglobulin [
6]. It is important to note however that the majority of anaplastic thyroid carcinomas also do not have a positive reaction to thyroglobulin [
7].
It has been suggested in more recent studies over the last 10 years that overall survival time is not significantly different in patients with or without thyroid metastases [
7], which differs from series published prior to 2000 [
9]. The impact of metastases to the thyroid on disease course may be the same as nonthyroid metastases, with prognosis dependent on the primary tumour and disease [
2,
3,
7,
8]. Interestingly, there has been no significant effect on overall survival shown following thyroidectomy in patients with TM [
7].